{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:00:57Z","timestamp":1785258057276,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,28]]},"DOI":"10.7759\/cureus.113522","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:21:07Z","timestamp":1785255667000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation of Ventricular Arrhythmias With Peak and Trough Levels of Oral Digoxin: A Prospective Ambulatory Electrocardiographic Study"],"prefix":"10.7759","author":[{"given":"Jyothi","family":"Vijay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2026.7335","article-title":"Digoxin in patients with symptomatic rheumatic heart disease: a randomized clinical trial","volume":"335","author":"Karthikeyan G","year":"2026","unstructured":"Karthikeyan G, Devasenapathy N, Ghosh A, et al.. Digoxin in patients with symptomatic rheumatic heart disease: a randomized clinical trial. JAMA. 2026, 335:2020-8. 10.1001\/jama.2026.7335","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/pcad.1999.0410247","article-title":"Cardiac glycosides in the next millennium","volume":"41","author":"Hauptman PJ","year":"1999","unstructured":"Hauptman PJ, Garg R, Kelly RA. Cardiac glycosides in the next millennium. Prog Cardiovasc Dis. 1999, 41:247-54. 10.1053\/pcad.1999.0410247","journal-title":"Prog Cardiovasc Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis Investigation Group","year":"1997","unstructured":"Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997, 336:525-33. 10.1056\/NEJM199702203360801","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.05.016","article-title":"Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial","volume":"12","author":"Lee AY","year":"2015","unstructured":"Lee AY, Kutyifa V, Ruwald MH, et al.. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial. Heart Rhythm. 2015, 12:2010-7. 10.1016\/j.hrthm.2015.05.016","journal-title":"Heart Rhythm"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.01.015","article-title":"Digoxin in atrial fibrillation?: leave it out of the medicine cabinet","volume":"71","author":"Turakhia MP","year":"2018","unstructured":"Turakhia MP. Digoxin in atrial fibrillation?: leave it out of the medicine cabinet. J Am Coll Cardiol. 2018, 71:1075-7. 10.1016\/j.jacc.2018.01.015","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.060","article-title":"Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study","volume":"64","author":"Turakhia MP","year":"2014","unstructured":"Turakhia MP, Santangeli P, Winkelmayer WC, et al.. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol. 2014, 64:660-8. 10.1016\/j.jacc.2014.03.060","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.060","article-title":"Digoxin and mortality in patients with atrial fibrillation","volume":"71","author":"Lopes RD","year":"2018","unstructured":"Lopes RD, Rordorf R, De Ferrari GM, et al.. Digoxin and mortality in patients with atrial fibrillation. J Am Coll Cardiol. 2018, 71:1063-74. 10.1016\/j.jacc.2017.12.060","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(75)90116-3","article-title":"Digitalis pharmacokinetics and metabolism","volume":"58","author":"Marcus FI","year":"1975","unstructured":"Marcus FI. Digitalis pharmacokinetics and metabolism. Am J Med. 1975, 58:452-9. 10.1016\/0002-9343(75)90116-3","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198759935.001.0001","article-title":"","author":"Kaski JC","year":"2019","unstructured":"Kaski JC, Kjeldsen KP. The ESC Handbook on Cardiovascular Pharmacotherapy. Kaski JC, Kjeldsen KP (ed): Oxford University Press, Oxford, United Kingdom; 2019. 10.1093\/med\/9780198759935.001.0001"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5885.132","article-title":"Pharmacokinetics of digoxin: interpreting bioavailability","volume":"4","author":"Sanchez N","year":"1973","unstructured":"Sanchez N, Sheiner LB, Halkin H, Melmon KL. Pharmacokinetics of digoxin: interpreting bioavailability. Br Med J. 1973, 4:132-4. 10.1136\/bmj.4.5885.132","journal-title":"Br Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609874","article-title":"Absorption of digoxin in severe right heart failure","volume":"15","author":"Ohnhaus EE","year":"1979","unstructured":"Ohnhaus EE, Vozeh S, Nuesch E. Absorption of digoxin in severe right heart failure. Eur J Clin Pharmacol. 1979, 15:115-20. 10.1007\/BF00609874","journal-title":"Eur J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.19.040179.000541","article-title":"Clinical pharmacokinetics","volume":"19","author":"Atkinson AJ Jr","year":"1979","unstructured":"Atkinson AJ Jr, Kushner W. Clinical pharmacokinetics. Annu Rev Pharmacol Toxicol. 1979, 19:105-27. 10.1146\/annurev.pa.19.040179.000541","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.5.484","article-title":"Caution regarding the use of pilot studies to guide power calculations for study proposals","volume":"63","author":"Kraemer HC","year":"2006","unstructured":"Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA. Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry. 2006, 63:484-9. 10.1001\/archpsyc.63.5.484","journal-title":"Arch Gen Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193924","article-title":"Digoxin for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"13","author":"Sethi NJ","year":"2018","unstructured":"Sethi NJ, Nielsen EE, Safi S, Feinberg J, Gluud C, Jakobsen JC. Digoxin for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. PLoS One. 2018, 13:e0193924. 10.1371\/journal.pone.0193924","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00461-4","article-title":"Relation of circadian ventricular ectopic activity to cardiac mortality","volume":"78","author":"Goldstein S","year":"1996","unstructured":"Goldstein S, Zoble RG, Akiyama T, et al.. Relation of circadian ventricular ectopic activity to cardiac mortality. Am J Cardiol. 1996, 78:881-5. 10.1016\/S0002-9149(96)00461-4","journal-title":"Am J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/517858-correlation-of-ventricular-arrhythmias-with-peak-and-trough-levels-of-oral-digoxin-a-prospective-ambulatory-electrocardiographic-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:21:08Z","timestamp":1785255668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/517858-correlation-of-ventricular-arrhythmias-with-peak-and-trough-levels-of-oral-digoxin-a-prospective-ambulatory-electrocardiographic-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.113522","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}